Clorox (CLX) Tops Q3 EPS by 6c; Trims FY EPS Outlook, Sees Sales at Top End
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Clorox Reports Q3 Fiscal Year 2018 Results, Updates Fiscal Year 2018 Outlook
May 2, 2018 6:30 AM EDTOAKLAND, Calif., May 2, 2018 /PRNewswire/ --Â The Clorox Company (NYSE: CLX) reported sales growth of 3 percent and diluted net earnings per share from continuing operations (diluted EPS) of $1.37, an increase of 5 percent, for its third quarter of fiscal year 2018, which ended March 31, 2018.
"We delivered solid sales growth of 3 percent, with gains in all U.S. segments and in our International segment, behind our 2020 Strategy,"Â said Chairman and CEO Benno Dorer. "Notably, we delivered these results on top of 4 percent sales growth in the year-ago quarter. Our focus on providing superior value to consumers... More
